|
Reported tolerability of niacin and placebo |
||
| Tolerability, No. (%) |
Niacin (n = 33) |
Placebo (n-35) |
|
|
||
| No effect |
0 (0) |
34 (97.1) |
| Easy to tolerate |
2 (6.1) |
1 (2.9) |
| Mildly unpleasant, but tolerable |
14 (42.4) |
0 (0) |
| Unpleasant, and difficult to tolerate |
11 (33.3) |
0 (0) |
| Intolerable, and would never take niacin again |
6 (18.2) |
0 (0) |
Mills et al. BMC Clinical Pharmacology 2003 3:4 doi:10.1186/1472-6904-3-4 |
||